Y-Intercept (Hong Kong) Ltd

Position in ZTS — Zoetis Inc.

CIK 1772875 HONG KONG, K3

Position in ZTS

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$1,872,091

-$10,550,769 QoQ

Shares Held

15,837

-81.3% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Y-Intercept (Hong Kong) Ltd holds $31,681,893 across 15 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	302,995	$9,126,209
2	VTRS	Viatris Inc	525,863	$7,104,409
3	PRGO	PERRIGO Co plc	447,451	$4,805,623
4	BIOA	BioAge Labs, Inc.	201,337	$3,521,384
5	ZTS	Zoetis Inc. This page	15,837	$1,872,091
6	SUPN	Supernus Pharmaceuticals, Inc.	20,236	$1,045,998
7	HLN	Haleon plc	93,822	$939,158
8	XERS	Xeris Biopharma Holdings, Inc.	161,793	$938,399

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,872,091	15,837	-81.3%	Shares	Sole	2026-04-27
2025-09-30	$12,422,860	84,902	+43.9%	Shares	Sole	2025-10-31
2025-06-30	$9,203,077	59,013	+371.7%	Shares	Sole	2025-08-01
2025-03-31	$2,060,100	12,512	-42.3%	Shares	Sole	2025-05-06
2024-12-31	$3,530,204	21,667	+35.2%	Shares	Sole	2025-02-04
2024-03-31	$2,711,928	16,027	-3.5%	Shares	Sole	2024-05-10
2023-09-30	$2,889,111	16,606	+525.9%	Shares	Sole	2023-11-14
2023-03-31	$441,565	2,653	-35.4%	Shares	Sole	2023-05-09
2022-12-31	$601,587	4,105	-85.3%	Shares	Sole	2023-02-14
2022-09-30	$4,143,519	27,942	+690.7%	Shares	Sole	2023-02-14
2022-03-31	$666,477	3,534	-36.1%	Shares	Sole	2022-05-16
2021-09-30	$1,073,400	5,529	+145.4%	Shares	Sole	2021-11-15
2020-12-31	$372,871	2,253	—	Shares	Sole	2021-02-05
No filing history on record for this holder in this stock.